Label‐free relative quantification of secreted proteins as a non‐invasive method for the quality control of chondrogenesis in bioengineered substitutes for cartilage repair. (14th July 2017)

• Record Type: Journal Article
• Authors: Henrionnet, Christel; Gillet, Pierre; Mainard, Didier; Vincourt, Jean‐Baptiste; Pinzano, Astrid
• Is Part Of: Journal of tissue engineering and regenerative medicine. Volume 12:Number 3(2018)
• Page Start: e1757
• Page End: e1766
• Publication Date: 2017-07-14
• Subjects: chondrocyte -- collagen -- LC‐MALDI -- mass spectrometry -- mesenchymal stem cell -- secretome; Tissue engineering -- Periodicals; Regeneration (Biology) -- Periodicals; 610.28
• DOI: 10.1002/term.2454
• Languages: English
• ISSNs: 1932-6254

Abstract

Abstract: Cartilage tissue engineering is making progress, but the competing available strategies still leave room for improvement and consensual overviews regarding the best combinations of scaffolds and cell sources are limited by the capacity to compare them directly. In addition, because most strategies involve autologous cell transfer, once these are optimized, the resulting implants require individual quality control prior to grafting in order to emphasize patient‐to‐patient differential responsiveness to engineering processes. Here, cartilage substitutes prepared from human mesenchymal stem cells undergoing chondrogenic differentiation within distinct scaffolds were used as pilot samples to investigate the pertinence of a novel method with the aim of characterizing the implants. The limits and advantages of analysing, by label‐free liquid chromatography‐coupled matrix‐assisted laser desorption and ionization (LC‐MALDI) mass spectrometry, the secreted proteome released into culture medium by engineered cartilage tissues were investigated and compared with more classically used methods for biomaterial characterization. This method did not require sacrificing the biomaterials and robustly evidenced their chondrogenic statuses. In more detail, the method highlighted differences between batches prepared from distinct donors. It was adapted to distinct scaffolds and allowed a comparison of the influence of individual engineering steps, such as growth factor combinations and oxygen tension. Finally, it evidenced subtle changes between replicate substitutes within a series, thereby distinguishing the least and most accomplished ones. We conclude that relative quantification of secreted proteins through label‐free LC‐MALDI will be useful, not only to orientate engineering methodologies, but also to ultimately provide non‐invasive quality control of engineered tissue substitutes for the repair of cartilage and possibly other connective tissues.